Romania's Antibiotice Iasi inaugurates 2.5 MW photovoltaic facility
Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iași Company, a pharmaceutical manufacturer with Romanian capital, became a member of the Sustainable Romania Coalition, the first platform for sustainable development established by the Embassy of Sustainability in Romania (ASR).
The state-owned drug manufacturer Antibiotice Iași made total investments worth RON 27.17 million (€5.4 million) in the first six months of the year for sustainable development.
Antibiotice Iaşi Company, the largest Romanian producer of generic drugs, will build a 2.5 MW photovoltaic plant. The company announced that it obtained from the Ministry of Investments and European Projects financing of RON4.08 million (€816,000) in this regard.
Achieving climate neutrality will unlock significant opportunities for development, economic growth, and technological innovation.
PPD Global, a leading distributor of premium beverages in Romania, has invested €500,000 to equip its Bucharest logistics center with modern photovoltaic panels, totaling 405 kWp of installed power.
ENGIE Romania has expanded its renewable energy portfolio by completing its first hybrid plant, combining wind and solar power, with a total installed capacity of 57 MW.
Restart Energy has completed the construction and installation of a photovoltaic project for the company Mobilaiud worth more than €850,000.
Transelectrica has signed with Georgian State Electrosystems, AzerEnerji, and MVM Electrical Works the shareholders' agreement for the Green Energy Corridor Power Company.